DANIEL W. GIL,JAMES A. BURKE,JOHN E. DONELLO,MOHAMMED I. DIBAS
申请号：
BR112014001538
公开号：
BR112014001538A2
申请日:
2012.07.22
申请国别(地区):
BR
年份:
2017
代理人:
摘要：
abstract the present invention relates to a method for treating retinal diseases and a method for retinal neuroprotection, in a patient in need thereof which comprises of administering a therapeutically effective amount of a pharmaceutical composition comprising a therapeutically effective amount of 4-bromo-n- ( imidazolidin-2-ylidene) -1h-benzimidazole-5-amine or pharmaceutically acceptable salts thereof. ************************************************** ************* Translation of the Summary Patent Summary: "Pharmaceutical compositions comprising 4-bromo-n- (imidazolidin-2-ylidene) -1h-benzimidazol-5-amine for treating diseases". retinals ". The present invention relates to a method for treating retinal diseases and a method for retinal neuroprotection in a patient in need thereof which comprises administering a therapeutically effective amount of a pharmaceutical composition comprising a therapeutically effective amount of 4-bromine. -n- (imidazolidin-2-ylidene) -1h-benzimidazol-5-amine or pharmaceutically acceptable salts thereof.abstract the present invention relates to a method for treating retinal diseases and a method for retinal neuroprotection, in a patient in need thereof which comprises of administering a therapeutically effective amount of a pharmaceutical composition comprising a therapeutically effective amount of 4-bromo-n-(imidazolidin-2-ylidene)-1h-benzimidazol-5-amine or pharmaceutically acceptable salts thereof. *************************************************************** tradução do resumo resumo patente de invenção: "composições farmacêuticas compreendendo 4-bromo-n-(imidazolidin-2-ilideno)-1h-benzimidazol-5-amina para tratamento de doenças retinais". a presente invenção refere-se a um método para tratamento de doenças retinais e um método para neuroproteção retinal em um paciente com necessidade do mesmo, o qual compreende administração de uma quantidade terapeuticamente eficaz de uma composição farmacêutica compreendendo uma quantidade
